ATE131620T1 - Verfahren zum frühzeitigen nachweis von lungenkrebs - Google Patents

Verfahren zum frühzeitigen nachweis von lungenkrebs

Info

Publication number
ATE131620T1
ATE131620T1 AT89303267T AT89303267T ATE131620T1 AT E131620 T1 ATE131620 T1 AT E131620T1 AT 89303267 T AT89303267 T AT 89303267T AT 89303267 T AT89303267 T AT 89303267T AT E131620 T1 ATE131620 T1 AT E131620T1
Authority
AT
Austria
Prior art keywords
lung cancer
early detection
development
samples
lung
Prior art date
Application number
AT89303267T
Other languages
English (en)
Inventor
James L Mulshine
Melvyn S Tockman
Prabodh K Gupta
John K Frost
Original Assignee
Univ Johns Hopkins
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Us Health filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE131620T1 publication Critical patent/ATE131620T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89303267T 1988-04-04 1989-04-03 Verfahren zum frühzeitigen nachweis von lungenkrebs ATE131620T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17746588A 1988-04-04 1988-04-04

Publications (1)

Publication Number Publication Date
ATE131620T1 true ATE131620T1 (de) 1995-12-15

Family

ID=22648707

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89303267T ATE131620T1 (de) 1988-04-04 1989-04-03 Verfahren zum frühzeitigen nachweis von lungenkrebs

Country Status (8)

Country Link
US (1) US5455159A (de)
EP (1) EP0336677B1 (de)
JP (2) JP2988630B2 (de)
KR (1) KR0141608B1 (de)
AT (1) ATE131620T1 (de)
AU (1) AU632469B2 (de)
CA (1) CA1340595C (de)
DE (1) DE68925058T2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544898A1 (de) * 1991-06-26 1993-06-09 The Biomembrane Institute Frühdiagnose von lungenkrebs mit gebrauch von anti-kohlenhydrat antikörper zustzungen
US5790761A (en) * 1992-12-11 1998-08-04 Heseltine; Gary L. Method and apparatus for the diagnosis of colorectal cancer
JP2000500322A (ja) 1995-10-02 2000-01-18 アメリカ合衆国 初期癌検出への使用のための上皮タンパク質及びそのｄｎａ
US5994062A (en) 1995-10-02 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Epithelial protein and DNA thereof for use in early cancer detection
US5955287A (en) * 1995-12-29 1999-09-21 Fernandez-Pol; Jose Alberto Method of determining level of biological substances elevated in the presence of cancer and other neoplasms
WO1998015835A1 (en) * 1996-10-08 1998-04-16 Inspire Pharmaceuticals, Inc. Method of early lung cancer detection via sputum induction and analysis of sputum to detect cancer associated substances
US6736785B1 (en) 1999-08-09 2004-05-18 Advanced Respiratory, Inc. Mechanical chest wall oscillator
US6379316B1 (en) * 1999-08-31 2002-04-30 Advanced Respiratory, Inc. Method and apparatus for inducing sputum samples for diagnostic evaluation
US20040158177A1 (en) * 1999-08-31 2004-08-12 Van Brunt Nicholas P. Pneumatic chest compression vest with front panel bib
US6916298B2 (en) * 1999-08-31 2005-07-12 Advanced Respiratory, Inc. Pneumatic chest compression vest with front panel air bladder
US6471663B1 (en) 1999-08-31 2002-10-29 American Biosystems, Inc. Chest compression vest with connecting belt
US6415791B1 (en) 1999-10-04 2002-07-09 American Biosystems, Inc. Airway treatment apparatus with cough inducement
US7316658B2 (en) * 2003-09-08 2008-01-08 Hill-Rom Services, Inc. Single patient use vest
EP1835929B8 (de) 2005-01-06 2016-07-27 Novo Nordisk A/S Behandlungen und verfahren mit anti-kir-kombination
US7785280B2 (en) 2005-10-14 2010-08-31 Hill-Rom Services, Inc. Variable stroke air pulse generator
KR20080073740A (ko) * 2005-11-10 2008-08-11 유니버시티 오브 캔터키 폐암 진단 검사
US8460223B2 (en) 2006-03-15 2013-06-11 Hill-Rom Services Pte. Ltd. High frequency chest wall oscillation system
US20080113350A1 (en) * 2006-11-09 2008-05-15 Terstappen Leon W M M Blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (FISH)
US9744097B2 (en) 2012-06-29 2017-08-29 Hill-Rom Services Pte. Ltd. Wearable thorax percussion device
US9549869B2 (en) 2012-06-29 2017-01-24 Hill-Rom Canado Respiratory Ltd. Wearable thorax percussion device
US11471366B2 (en) 2016-08-22 2022-10-18 Hill-Rom Services Pte. Ltd. Percussion therapy apparatus and methods thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
US4865998A (en) * 1983-03-11 1989-09-12 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human lung cancers and method
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
US4687733A (en) * 1984-01-30 1987-08-18 Ohio State University Early cancer detection method
US4782015A (en) * 1984-03-30 1988-11-01 Syntex (U.S.A.) Inc. Method for determining the presence of malignant cells
US4886745A (en) * 1984-03-30 1989-12-12 Syntex Inc. Monoclonal antibody specific for human basal cell surface antigen
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US4683200A (en) * 1984-05-17 1987-07-28 Setsuo Hirohashi Monoclonal antibody to human cancer antigen and method for producing same
US4731326A (en) * 1984-06-04 1988-03-15 Ortho Diagnostic Systems Inc. Disease diagnosis by detection of shed normal tissue antigens
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
US4873188A (en) * 1985-05-28 1989-10-10 Oncogen Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies
US4816402A (en) * 1986-01-07 1989-03-28 Northwestern University Murine hybridoma and diagnostic antibody produced thereby
EP0232871A3 (de) * 1986-02-07 1989-03-15 Yoshitomi Pharmaceutical Industries, Ltd. Menschlicher monoklonaler Antikörper, Hybridoma zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
JPH0296658A (ja) 1990-04-09
EP0336677B1 (de) 1995-12-13
AU3117289A (en) 1989-10-05
CA1340595C (en) 1999-06-15
AU632469B2 (en) 1993-01-07
DE68925058D1 (de) 1996-01-25
DE68925058T2 (de) 1996-05-09
US5455159A (en) 1995-10-03
JP2988630B2 (ja) 1999-12-13
JPH116836A (ja) 1999-01-12
KR0141608B1 (ko) 1998-06-15
EP0336677A1 (de) 1989-10-11
KR890015714A (ko) 1989-11-25

Similar Documents

Publication Publication Date Title
ATE131620T1 (de) Verfahren zum frühzeitigen nachweis von lungenkrebs
DK1078264T3 (da) Tumormarkörer
CA2384579A1 (en) Early cancer tumor marker
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
PL377743A1 (pl) Sposoby identyfikowania nowotworów, które są wrażliwe na leczenie przeciwciałami anty-ErbB2
DE69729156D1 (de) Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA)
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
EP0102381A4 (de) VERFAHREN ZUR IDENTIFIZIERUNG UND REINIGUNG VON MIT MENSCHLICHEM LUNGENTUMOR ASSOZIIERTEN ANTIGENEN (hLTAA) UND KLINISCHER NACHWEIS UND BESTIMMUNG DIESER ANTIGENE.
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
GB2424273B (en) Method for preparing tumour marker protein
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
ATE262179T1 (de) Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten
DK0991945T4 (da) Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
ATE408843T1 (de) Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
DE69621837T2 (de) Methoden zur feststellung von alzheimerscher krankheit
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE222366T1 (de) Immunohistochemischer nachweis des proliferativen zustandes von karzinoma
DE60034334D1 (de) Diagnostisches verfahren für chronische obstruktive lungen krankheit
WO2004016065A3 (es) SISTEMA Y PROCEDIMIENTO INMUNOCROMATOGRÁFICO PARA LA INDENTIFICACIÓN SIMULTÁNEA DE ANTICUERPOS FRENTE A AGA Y t-TG, Y SU USO EN EL DIAGNOSTICO DE ENFERMEDAD CELIACA
DE69229948D1 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN
ATE77884T1 (de) Fluorometrischer test von chymopapain und reagenzien zur durchfuehrung desselben.
Ohkawa et al. An improved sensitive assay method for the heterogeneity of α-foetoprotein: possible application for early differential diagnosis
DE69524107T2 (de) Bestimmung von freiem und komplexiertem trypsinogen-2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties